These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 5284370)

  • 1. [In vitro study of the sensitivity of osteosarcoma to antineoplastic agents: the antimitogram].
    Morasca L; Roy-Camille R
    Presse Med (1893); 1971 Jun; 79(32):1453-4. PubMed ID: 5284370
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro studies on the cytotoxic properties of 9-amino-nitroacridine derivatives.
    Konopa J; Ledóchowski A; Matuszkiewicz A; Jereczek-Morawska E
    Neoplasma; 1969; 16(2):171-9. PubMed ID: 5822919
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy resistance in osteosarcoma: current challenges and future directions.
    Chou AJ; Gorlick R
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1075-85. PubMed ID: 16831079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons and osteosarcoma.
    Strander H
    Cytokine Growth Factor Rev; 2007; 18(5-6):373-80. PubMed ID: 17683971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemetrexed, a multitargeted antifolate drug, demonstrates lower efficacy in comparison to methotrexate against osteosarcoma cell lines.
    Bodmer N; Walters DK; Fuchs B
    Pediatr Blood Cancer; 2008 Apr; 50(4):905-8. PubMed ID: 17534933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Cancer Invest; 2006 Feb; 24(1):1-8. PubMed ID: 16466985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concepts for controlling drug-resistant tumor cells.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Corbett TH; Griswold DP
    Eur J Cancer (1965); 1980; Suppl 1():199-211. PubMed ID: 6947891
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary study of chemosenstivity tests in osteosarcoma using a histoculture drug response assay.
    Lee SY; Jeon DG; Cho WH; Song WS; Kim MB; Park JH
    Anticancer Res; 2006; 26(4B):2929-32. PubMed ID: 16886615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer effects of zoledronic acid against human osteosarcoma cells.
    Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W
    J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoidance of doxorubicin resistance in osteosarcoma cells using a new quinoline derivative, MS-209.
    Takeshita H; Kusuzaki K; Tsuji Y; Hirata M; Hashiguchi S; Nakamura S; Murata H; Ashihara T; Hirasawa Y
    Anticancer Res; 1998; 18(2A):739-42. PubMed ID: 9615713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB
    Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actinomycin D: effects on Ridgway osteogenic sarcoma in mice.
    Schwartz HS; Sodergren JE; Sternberg SS; Philips FS
    Cancer Res; 1966 Sep; 26(9):1873-9. PubMed ID: 5224225
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro chemosensitivity assay for human osteosarcoma using tumor xenografts.
    Fujisaki T; Wada T; Takahashi M; Yamawaki S; Ishii S
    Clin Orthop Relat Res; 1995 Apr; (313):279-85. PubMed ID: 7641491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age responses of cultured mammalian cells to cytotoxic drugs.
    Mauro F; Madoc-Jones H
    Cancer Res; 1970 May; 30(5):1397-408. PubMed ID: 5426942
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
    Sun J; Fu ZM; Fang CQ; Li JH
    Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pre-surgical continuous arterial infusion of antineoplastic agents in osteosarcoma].
    Oe H
    Igaku Kenkyu; 1971 Jul; 41(5):353-63. PubMed ID: 5287045
    [No Abstract]   [Full Text] [Related]  

  • 18. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
    Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
    Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different sensitivity to actinomycin D of biopsies of human tumors cultivated in vitro.
    Morasca L; Balconi G
    Eur J Cancer (1965); 1973 Apr; 9(4):301-4. PubMed ID: 4521544
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
    Mackie PS; Fisher JL; Zhou H; Choong PF
    Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.